Role Of Vitamin-D Supplementation In TB/HIV Co-Infected Patients

References

• WHO. Global Tuberculosis Control: Surveillance, Planning, Financing: WHO Report 2008. World Health Organization; 2008.
   Google Scholar
• Amelio P, Portevin D, Hella J, et al. HIV infection functionally impairs Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses. J Virol. 2019;93(5):e01728–e017218. doi:10.1128/JVI.01728-1830541853
   PubMed Web of Science ®Google Scholar
• Campbell GR, Spector SA. Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1. Autophagy. 2012;8(10):1523–1525. doi:10.4161/auto.2115422892387
   PubMed Web of Science ®Google Scholar
• WHO. Global Tuberculosis Report 2018; 2018 Geneva:World Health Organization Licence: CC BY-NC-SA 3.0. IGO. WHO/CDS/TB/2018.20 Available from http://apps.who.int/iris/bitstream.
   Google Scholar
• Harries A, Zachariah R, Lawn S. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa [State of the art series. Tuberculosis. Edited by ID Rusen. Number 3 in the series]. Int J Tuberculosis Lung Dis. 2009;13(1):6–16.
   PubMed Web of Science ®Google Scholar
• Godfrey-Faussett P, Ayles H. The impact of HIV on tuberculosis control–towards concerted action. Lepr Rev. 2002;73(4):376–385.12549845
   PubMed Web of Science ®Google Scholar
• Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis. 2010;10(7):455–463. doi:10.1016/S1473-3099(10)70093-120610327
   PubMed Web of Science ®Google Scholar
• O’Donnell MR, Daftary A, Frick M, et al. Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. Int J Tuberculosis Lung Dis. 2016;20(4):430–434. doi:10.5588/ijtld.15.0360
   Web of Science ®Google Scholar
• Nansera D, Graziano F, Friedman D, Bobbs M, Jones A, Hansen K. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberculosis Lung Dis. 2011;15(11):1522–1528. doi:10.5588/ijtld.10.0701
   Web of Science ®Google Scholar
• Houben R, Crampin A, Ndhlovu R, et al. Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberculosis Lung Dis. 2011;15(1):24–31.
   PubMed Web of Science ®Google Scholar
• Crampin AC, Mwaungulu JN, Mwaungulu FD, et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS. 2010;24(3):417. doi:10.1097/QAD.0b013e32832f51cf20042847
   PubMed Web of Science ®Google Scholar
• Gupta A, Wood R, Kaplan R, Bekker L-G, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One. 2012;7(3):e34156. doi:10.1371/journal.pone.003415622479548
   PubMed Web of Science ®Google Scholar
• Patel NR, Zhu J, Tachado SD, et al. HIV impairs TNF-α mediated macrophage apoptotic response to Mycobacterium tuberculosis. J Immunol. 2007;179(10):6973–6980. doi:10.4049/jimmunol.179.10.697317982088
   PubMed Web of Science ®Google Scholar
• Ignatowicz L. Studies on the Host Immune Response during Pulmonary TB and during M. Tuberculosis/HIV Co-Infection: Inst För Mikrobiologi, Tumör-Och Cellbiologi/Dept of Microbiology, Tumor and Molecular biology; 2012.
   Google Scholar
• Diedrich CR, Flynn JL. HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun. 2011;79(4):1407–1417. doi:10.1128/IAI.01126-1021245275
   PubMed Web of Science ®Google Scholar
• Singh SK, Larsson M, Schön T, Stendahl O, Blomgran R. HIV interferes with the dendritic cell–T cell axis of macrophage activation by shifting Mycobacterium tuberculosis–specific CD4 T cells into a dysfunctional phenotype. J Immunol. 2019;202(3):816–826. doi:10.4049/jimmunol.180052330593540
   PubMed Web of Science ®Google Scholar
• Dezzutti CS, Hladik F. Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities. Curr HIV/AIDS Rep. 2013;10(1):12–20. doi:10.1007/s11904-012-0148-223224426
   PubMed Web of Science ®Google Scholar
• Jiang W, Lederman MM, Salkowitz JR, Rodriguez B, Harding CV, Sieg SF. Impaired monocyte maturation in response to CpG oligodeoxynucleotide is related to viral RNA levels in human immunodeficiency virus disease and is at least partially mediated by deficiencies in alpha/beta interferon responsiveness and production. J Virol. 2005;79(7):4109–4119. doi:10.1128/JVI.79.7.4109-4119.200515767412
   PubMed Web of Science ®Google Scholar
• Muthumani K, Hwang DS, Choo AY, et al. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. Int Immunol. 2004;17(2):103–116. doi:10.1093/intimm/dxh19015611322
   PubMed Web of Science ®Google Scholar
• Bell LC, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nature Rev Microbiol. 2018;16(2):80. doi:10.1038/nrmicro.2017.12829109555
   PubMed Web of Science ®Google Scholar
• Wimalawansa S. Biology of vitamin D. J Steroids Horm Sci. 2019;10(198):2.
   Google Scholar
• Bartley J. Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther. 2010;8(12):1359–1369. doi:10.1586/eri.10.10221133662
   PubMed Web of Science ®Google Scholar
• Cannell J, Hollis B, Zasloff M, Heaney R. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother. 2008;9(1):107–118. doi:10.1517/14656566.9.1.10718076342
   PubMed Web of Science ®Google Scholar
• Larcombe L, Orr P, Turner-Brannen E, Slivinski CR, Nickerson PW, Mookherjee N. Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dene First Nations cohort. PLoS One. 2012;7(7):e40692. doi:10.1371/journal.pone.004069222866178
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Koeffler HP, Donaldson CA, Pike JW, Haussler MR. 1, 25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol. 1984;98(2):391–398. doi:10.1083/jcb.98.2.3916319426
   PubMed Web of Science ®Google Scholar
• Jones G, Prosser DE, Kaufmann M. The activating enzymes of vitamin D metabolism (25-and 1α-hydroxylases). Vitamin D. 2018;57–79.
   Google Scholar
• Fabri M, Stenger S, Shin D-M, et al. Vitamin D is required for IFN-γ–mediated antimicrobial activity of human macrophages. Sci Transl Med. 2011;3(104):104ra2–ra2. doi:10.1126/scitranslmed.3003045
   Web of Science ®Google Scholar
• Zhao C, Liu L, Lehrer RI. Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett. 1994;346(2–3):285–288.8013647
   PubMed Web of Science ®Google Scholar
• Wang J, Wong ES, Whitley JC, et al. Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options. PLoS One. 2011;6(8):e24030. doi:10.1371/journal.pone.002403021912615
   PubMed Web of Science ®Google Scholar
• Fiske CT, Blackman A, Maruri F, et al. Increased vitamin D receptor expression from macrophages after stimulation with M. tuberculosis among persons who have recovered from extrapulmonary tuberculosis. BMC Infect Dis. 2019;19(1):366. doi:10.1186/s12879-019-3958-731039752
   PubMed Web of Science ®Google Scholar
• White JH. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J Steroid Biochem Mol Biol. 2010;121(1–2):234–238. doi:10.1016/j.jsbmb.2010.03.03420302931
   PubMed Web of Science ®Google Scholar
• Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007;179(4):2060–2063. doi:10.4049/jimmunol.179.4.206017675463
   PubMed Web of Science ®Google Scholar
• Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144:138–145. doi:10.1016/j.jsbmb.2013.11.00324239505
   PubMed Web of Science ®Google Scholar
• Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–1086S. doi:10.1093/ajcn/87.4.1080S18400738
   PubMed Web of Science ®Google Scholar
• Campbell GR, Spector SA, Deretic V. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 2012;8(5):e1002689. doi:10.1371/journal.ppat.100268922589721
   PubMed Web of Science ®Google Scholar
• Dini C, Bianchi A. The potential role of vitamin D for prevention and treatment of tuberculosis and infectious diseases. Annali dell’Istituto Superiore Di Sanita. 2012;48:319–327. doi:10.4415/ANN_12_03_13
   PubMed Web of Science ®Google Scholar
• Yamshchikov AV, Oladele A, Leonard MK Jr, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D as adjunctive therapy in refractory pulmonary tuberculosis: a case report. South Med J. 2009;102(6):649. doi:10.1097/SMJ.0b013e3181a5d37e19434014
   PubMed Web of Science ®Google Scholar
• Morcos M, Gabr A, Samuel S, Kamel M, Michail R. Vitamin D administration to tuberculous children and its value. Boll Chim Farm. 1998;137(5):157–164.9689902
   PubMedGoogle Scholar
• Jo EK. Innate immunity to mycobacteria: vitamin D and autophagy. Cell Microbiol. 2010;12(8):1026–1035. doi:10.1111/j.1462-5822.2010.01491.x20557314
   PubMed Web of Science ®Google Scholar
• Coussens AK, Martineau AR, Wilkinson RJ. Anti-inflammatory and antimicrobial actions of vitamin D in combating TB/HIV. Scientifica. 2014;2014.
   Google Scholar
• Ranjbar S, Jasenosky LD, Chow N, Goldfeld AE. Regulation of Mycobacterium tuberculosis-dependent HIV-1 transcription reveals a new role for NFAT5 in the toll-like receptor pathway. PLoS Pathog. 2012;8(4):e1002620. doi:10.1371/journal.ppat.100262022496647
   PubMed Web of Science ®Google Scholar
• Narendran G, Andrade BB, Porter BO, et al. Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction. PLoS One. 2013;8(5):e63541. doi:10.1371/journal.pone.006354123691062
   PubMed Web of Science ®Google Scholar
• Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8(8):516–523. doi:10.1016/S1473-3099(08)70184-118652998
   PubMed Web of Science ®Google Scholar
• Meintjes G, Wilkinson KA, Rangaka MX, et al. Type 1 helper T cells and FoxP3-positive T cells in HIV–tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med. 2008;178(10):1083–1089. doi:10.1164/rccm.200806-858OC18755923
   PubMed Web of Science ®Google Scholar
• Conesa-Botella A, Meintjes G, Coussens AK, et al. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin Infect Dis. 2012;55(7):1004–1011. doi:10.1093/cid/cis57722715179
   PubMed Web of Science ®Google Scholar
• Tadokera R, Meintjes G, Skolimowska KH, et al. Hypercytokinaemia accompanies HIV–tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J. 2011;37(5):1248–1259. doi:10.1183/09031936.0009101020817712
   PubMed Web of Science ®Google Scholar
• Tadokera R, Meintjes GA, Wilkinson KA, et al. Matrix metalloproteinases and tissue damage in HIV‐tuberculosis immune reconstitution inflammatory syndrome. Eur J Immunol. 2014;44(1):127–136. doi:10.1002/eji.20134359324136296
   PubMed Web of Science ®Google Scholar
• Nursym EW, Amin Z, Rumende CM. The effect of Vitamin D as supplmentary treatment in patients with moderately advanced pulmonary tuberclosis lesion. Acta Med Indones. 2006;38(1):3–5.16479024
   PubMedGoogle Scholar